R. M. MacKie

2.4k total citations
38 papers, 1.8k citations indexed

About

R. M. MacKie is a scholar working on Oncology, Dermatology and Epidemiology. According to data from OpenAlex, R. M. MacKie has authored 38 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 12 papers in Dermatology and 10 papers in Epidemiology. Recurrent topics in R. M. MacKie's work include Cutaneous Melanoma Detection and Management (19 papers), melanin and skin pigmentation (7 papers) and Cutaneous lymphoproliferative disorders research (6 papers). R. M. MacKie is often cited by papers focused on Cutaneous Melanoma Detection and Management (19 papers), melanin and skin pigmentation (7 papers) and Cutaneous lymphoproliferative disorders research (6 papers). R. M. MacKie collaborates with scholars based in United Kingdom and United States. R. M. MacKie's co-authors include T Aitchison, David Hole, John English, Anthony J. Swerdlow, C.J. O’Doherty, J. Clark, V.R. Doherty, Catherine E. Thomas, A. J. Cochran and W G Spilg and has published in prestigious journals such as The Lancet, British Journal of Cancer and Pharmacology & Therapeutics.

In The Last Decade

R. M. MacKie

38 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. M. MacKie United Kingdom 20 1.1k 786 486 306 273 38 1.8k
R. L. Barnhill United States 18 900 0.9× 455 0.6× 218 0.4× 165 0.5× 330 1.2× 29 1.4k
Arthur R. Rhodes United States 26 1.6k 1.5× 1.0k 1.3× 578 1.2× 453 1.5× 351 1.3× 60 2.4k
V.R. Doherty United Kingdom 23 765 0.7× 581 0.7× 588 1.2× 118 0.4× 398 1.5× 39 1.6k
Geoffrey Strutton Australia 18 380 0.4× 690 0.9× 182 0.4× 160 0.5× 283 1.0× 44 1.6k
J J Bonerandi France 19 742 0.7× 452 0.6× 369 0.8× 76 0.2× 317 1.2× 43 1.3k
Stuart R. Lessin United States 32 990 0.9× 2.0k 2.5× 833 1.7× 204 0.7× 429 1.6× 67 3.2k
Rafael Botella‐Estrada Spain 28 1.0k 1.0× 1.0k 1.3× 754 1.6× 190 0.6× 371 1.4× 187 2.3k
Beate Volkmer Germany 19 805 0.8× 690 0.9× 506 1.0× 101 0.3× 243 0.9× 42 1.4k
Elena Sotiriou Greece 25 594 0.6× 1.2k 1.5× 1.1k 2.3× 173 0.6× 185 0.7× 96 2.2k
R.M. MacKie United Kingdom 18 558 0.5× 237 0.3× 266 0.5× 139 0.5× 266 1.0× 37 932

Countries citing papers authored by R. M. MacKie

Since Specialization
Citations

This map shows the geographic impact of R. M. MacKie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. M. MacKie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. M. MacKie more than expected).

Fields of papers citing papers by R. M. MacKie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. M. MacKie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. M. MacKie. The network helps show where R. M. MacKie may publish in the future.

Co-authorship network of co-authors of R. M. MacKie

This figure shows the co-authorship network connecting the top 25 collaborators of R. M. MacKie. A scholar is included among the top collaborators of R. M. MacKie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. M. MacKie. R. M. MacKie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McAllister, E J, et al.. (2000). Rising levels of serum S100 protein precede other evidence of disease progression in patients with malignant melanoma. British Journal of Dermatology. 143(2). 269–274. 61 indexed citations
2.
MacKie, R. M., David Hole, Annette Evans, et al.. (1997). Incidence, mortality and survival in cutaneous malignant melanoma in Scotland 1979???1994. Melanoma Research. 7(Supplement 1). S74–S74. 15 indexed citations
3.
MacKie, R. M.. (1997). Secondary prevention of cutaneous malignant melanoma. Melanoma Research. 7(SUPPLEMENT 2). S155–S155. 10 indexed citations
4.
Gupta, Gunjan, et al.. (1997). The labial melanotic macule: a review of 79 cases. British Journal of Dermatology. 136(5). 772–775. 14 indexed citations
5.
Burden, A. David, G.I. Stables, Ian Campbell, William Thomson, & R. M. MacKie. (1996). Mdm‐2 is not induced by p53 in human keratinocytes in vivo. Journal of Cutaneous Pathology. 23(1). 25–29. 6 indexed citations
6.
MacKie, R. M., et al.. (1996). Partial Characterisation of Human Melanoma Cell-Derived Factors that Stimulate Fibroblast Glycosaminoglycan Synthesis. Pathobiology. 64(5). 262–268. 2 indexed citations
7.
MacKie, R. M.. (1993). The march of melanoma. Clinical and Experimental Dermatology. 18(1). 1–4. 6 indexed citations
8.
Botella, R. & R. M. MacKie. (1993). Cutaneous lymphadenoma: a case report and review of the literature. British Journal of Dermatology. 128(3). 339–341. 19 indexed citations
9.
MacKie, R. M.. (1993). Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups. The Lancet. 341(8861). 1618–1620. 91 indexed citations
10.
Perkins, William, Ian W. Campbell, Irene M. Leigh, & R. M. MacKie. (1992). Keratin expression in normal skin and epidermal neoplasms demonstrated by a panel of monoclonal antibodies. Journal of Cutaneous Pathology. 19(6). 476–482. 40 indexed citations
11.
Stables, G.I., V.R. Doherty, & R. M. MacKie. (1992). Nine years' experience of BELD combination chemotherapy (bleomycin, vindesine, CCNU and DTIC) for metastatic melanoma. British Journal of Dermatology. 127(5). 505–508. 5 indexed citations
12.
Tillman, David M., et al.. (1991). Stage II melanoma in the West of Scotland, 1976–1985: Prognostic factors for survival. European Journal of Cancer and Clinical Oncology. 27(7). 870–876. 15 indexed citations
13.
Campo, M. Saveria, et al.. (1989). Novel variants of human papillomavirus type 2 in warts from immunocompromised individuals. British Journal of Dermatology. 121(5). 571–576. 11 indexed citations
14.
MacKie, R. M., et al.. (1989). Bone changes associated with oral retinoid theraphy. Pharmacology & Therapeutics. 40(1). 137–144. 21 indexed citations
15.
Doherty, V.R. & R. M. MacKie. (1988). Experience of a public education programme on early detection of cutaneous malignant melanoma.. BMJ. 297(6645). 388–391. 102 indexed citations
16.
Swerdlow, Anthony J., et al.. (1988). Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanoma.. BMJ. 297(6649). 647–650. 135 indexed citations
17.
Swerdlow, Anthony J., R. M. MacKie, C.J. O’Doherty, et al.. (1988). Site-specific melanocytic naevus counts as predictors of whole body naevi. British Journal of Dermatology. 118(5). 641–644. 30 indexed citations
18.
Swerdlow, Anthony J., John English, R. M. MacKie, et al.. (1986). Benign melanocytic naevi as a risk factor for malignant melanoma.. BMJ. 292(6535). 1555–1559. 254 indexed citations
19.
MacKie, R. M., et al.. (1985). Comparative study of three methods of plastic embedding in diagnostic dermatopathology.. Journal of Clinical Pathology. 38(12). 1397–1399. 1 indexed citations
20.
MacKie, R. M., W G Spilg, Catherine E. Thomas, & A. J. Cochran. (1972). CELL-MEDIATED IMMUNITY IN PATIENTS WITH MALIGNANT MELANOMA. British Journal of Dermatology. 87(6). 523–528. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026